Mapping blood system changes offers new hope for leukemia treatments
Researchers at University of California San Diego School of Medicine and their colleagues have developed the first comprehensive map of ...
Tag: Myeloid Leukemia
UC's Eric Vick receives major grants to advance research into combination therapy for leukemia
The University of Cincinnati Cancer Center's Eric Vick, MD, PhD, has been awarded a nearly $215,000 Career Development Award from ...
%2c_analyze_by_microscope-Jarun_Ontakrai_8864dd9cfb3b4dff9a913aede7a7c915-620x480.jpg "Leukemia cells depend on P-bodies for growth and survival")
Leukemia cells depend on P-bodies for growth and survival
An international team of scientists has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth. Researchers ...
Novel therapy can improve the prognosis of relapsed/refractory acute myeloid leukemia
Relapsed/refractory acute myeloid leukemia (AML), a so-called blood cancer, has an extremely poor prognosis because of resistance to anti-cancer drugs ...
Novel vaccine approach targets AML and other blood cancers
Acute myeloid leukemia (AML) is a type of blood cancer that forms in the soft marrow of the bones, typically ...
,_analyze_by_microscope-Jarun_Ontakrai_8864dd9cfb3b4dff9a913aede7a7c915-620x480.jpg "ABT199/venetoclax synergism with thiotepa enhances cytotoxicity of chemo drugs in AML cells")
ABT199/venetoclax synergism with thiotepa enhances cytotoxicity of chemo drugs in AML cells
A new research paper was published in Oncotarget's Volume 15 on March 14, 2024, entitled, "ABT199/venetoclax synergism with thiotepa enhances ...
Rising survival rates for AML patients over 65 after allogeneic hematopoietic stem cell transplant
Bottom line: Among patients over 65 who received an allogeneic hematopoietic stem cell transplant (allo-HCT) for the treatment of acute ...
Study could pave the way for synergistic therapeutic combinations to better treat SF3B1-mutant MDS
A new study from researchers with Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and ...
MD Anderson and Rigel partner to expand olutasidenib evaluation in AML and other cancers
The University of Texas MD Anderson Cancer Center and Rigel Pharmaceuticals, Inc. today announced a multi-year strategic development collaboration to ...
Chronic inflammation's influence on TP53 mutations in leukemia evolution explored in new study
In a recent study published in Nature Genetics, researchers performed an allelic-level single-cellular multi-omics evaluation of hematopoietic stem/progenitor cells (HSPCs) ...
